Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Change in Cash (2016 - 2025)

Historic Change in Cash for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to $6.5 million.

  • Neogen's Change in Cash fell 6731.29% to $6.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $5.1 million, marking a year-over-year increase of 10779.6%. This contributed to the annual value of -$41.6 million for FY2025, which is 66446.89% down from last year.
  • Per Neogen's latest filing, its Change in Cash stood at $6.5 million for Q4 2025, which was down 6731.29% from $9.9 million recorded in Q3 2025.
  • In the past 5 years, Neogen's Change in Cash registered a high of $96.1 million during Q2 2023, and its lowest value of -$50.1 million during Q3 2024.
  • Moreover, its 5-year median value for Change in Cash was $1.4 million (2022), whereas its average is $1.6 million.
  • In the last 5 years, Neogen's Change in Cash soared by 592923.46% in 2023 and then tumbled by 42153.67% in 2024.
  • Over the past 5 years, Neogen's Change in Cash (Quarter) stood at -$20.2 million in 2021, then soared by 64.8% to -$7.1 million in 2022, then skyrocketed by 479.44% to $26.9 million in 2023, then dropped by 26.66% to $19.8 million in 2024, then tumbled by 67.31% to $6.5 million in 2025.
  • Its last three reported values are $6.5 million in Q4 2025, $9.9 million for Q3 2025, and $1.3 million during Q2 2025.